• Attempted propoganda
    Attempted propoganda
    Like
    Love
    Wow
    3
    · 0 Comentários ·0 Compartilhamentos ·83K Visualizações ·0 Anterior
  • In the original Arthur book Arthur, an Aardvark, is bullied for his nose, which he eventually accepts and embraces. In the following books Arthur apparently has had a nose job.
    In the original Arthur book Arthur, an Aardvark, is bullied for his nose, which he eventually accepts and embraces. In the following books Arthur apparently has had a nose job.
    Like
    Love
    Wow
    3
    · 0 Comentários ·0 Compartilhamentos ·12K Visualizações ·0 Anterior
  • They're the Captain now
    They're the Captain now
    Like
    Love
    Wow
    3
    · 0 Comentários ·0 Compartilhamentos ·2K Visualizações ·0 Anterior
  • Global Afamelanotide Market (2024–2032): USD 136.27M to USD 258.01M Growth at 9.1% CAGR
    Global Afamelanotide Market is expected to grow from USD 136.27 million in 2024 to USD 258.01 million by 2032, registering a strong CAGR of 9.1% during 2025–2032. Market expansion is fueled by rising cases of rare phototoxic disorders such as Erythropoietic Protoporphyria (EPP), increased awareness about orphan diseases, and advancements in melanocortin-based peptide therapies.Afamelanotide, marketed as SCENESSE®, is the first and only FDA- and EMA-approved treatment for EPP. By stimulating melanin production, it offers significant photoprotection and improves sunlight tolerance, making it a breakthrough therapy for patients suffering from severe light sensitivity. Clinical pipelines exploring applications in vitiligo, photodermatoses, and select neurological disorders are further expanding market potential.
    Global Afamelanotide Market (2024–2032): USD 136.27M to USD 258.01M Growth at 9.1% CAGR Global Afamelanotide Market is expected to grow from USD 136.27 million in 2024 to USD 258.01 million by 2032, registering a strong CAGR of 9.1% during 2025–2032. Market expansion is fueled by rising cases of rare phototoxic disorders such as Erythropoietic Protoporphyria (EPP), increased awareness about orphan diseases, and advancements in melanocortin-based peptide therapies.Afamelanotide, marketed as SCENESSE®, is the first and only FDA- and EMA-approved treatment for EPP. By stimulating melanin production, it offers significant photoprotection and improves sunlight tolerance, making it a breakthrough therapy for patients suffering from severe light sensitivity. Clinical pipelines exploring applications in vitiligo, photodermatoses, and select neurological disorders are further expanding market potential.
    0 Comentários ·0 Compartilhamentos ·362 Visualizações ·0 Anterior
  • Global Atomizing Iron Powder Market (2025–2032): USD 971M to USD 1.234B Growth at 3.6% CAGR
    Global Atomizing Iron Powder Market is experiencing steady growth, rising from USD 971 million in 2025 to USD 1.234 billion by 2032, driven by a 3.6% CAGR. Atomized iron powder—produced through high-pressure water atomization of molten iron—offers high purity, superior compressibility, excellent sintering performance, and uniform spherical particle structure, making it the preferred material in powder metallurgy, automotive components, aerospace engineering, and industrial machinery.Demand continues to increase as industries shift toward advanced manufacturing technologies, including metal injection molding (MIM), additive manufacturing, and precision-engineered parts. The market benefits from sustainability trends, as atomized iron powder supports material recycling, waste reduction, and circular economy goals. However, high production energy consumption and raw material supply chain volatility pose challenges.Asia-Pacific dominates the market due to its strong manufacturing base, while North America and Europe maintain stable demand driven by innovation, automotive production, and high-value industrial applications. Supported by technological advancements and expanding industrialization across emerging regions, the atomizing iron powder market presents significant opportunities for manufacturers, investors, and industry stakeholders.
    Global Atomizing Iron Powder Market (2025–2032): USD 971M to USD 1.234B Growth at 3.6% CAGR Global Atomizing Iron Powder Market is experiencing steady growth, rising from USD 971 million in 2025 to USD 1.234 billion by 2032, driven by a 3.6% CAGR. Atomized iron powder—produced through high-pressure water atomization of molten iron—offers high purity, superior compressibility, excellent sintering performance, and uniform spherical particle structure, making it the preferred material in powder metallurgy, automotive components, aerospace engineering, and industrial machinery.Demand continues to increase as industries shift toward advanced manufacturing technologies, including metal injection molding (MIM), additive manufacturing, and precision-engineered parts. The market benefits from sustainability trends, as atomized iron powder supports material recycling, waste reduction, and circular economy goals. However, high production energy consumption and raw material supply chain volatility pose challenges.Asia-Pacific dominates the market due to its strong manufacturing base, while North America and Europe maintain stable demand driven by innovation, automotive production, and high-value industrial applications. Supported by technological advancements and expanding industrialization across emerging regions, the atomizing iron powder market presents significant opportunities for manufacturers, investors, and industry stakeholders.
    0 Comentários ·0 Compartilhamentos ·565 Visualizações ·0 Anterior
Páginas Impulsionadas